The Economic Times daily newspaper is available online now.

    Stocks in news: LIC, SBI Cards, Bharti Airtel, Zomato, Vodafone Idea

    Synopsis

    The Board of SBI Cards has declared an interim dividend of Rs 2.5 per share for the financial year ending 2023-24. The company has also fixed a record date of March 28 for the proposed dividend.

    Stocks in newsAgencies
    Sudeep Bhatia has resigned as the CFO of Protean eGov Technologies with effect from June 14, 2024 citing personal reasons.
    Tracking Asian peers' sour sentiments, Indian markets declined on Tuesday, continuing its recent pessimism. Analysts say the correction was also triggered by concerns over premium valuations and the delay of rate cuts by the US Fed due to hotter than expected inflation.

    In today's trade, shares of LIC, SBI Cards, Bharti Airtel, Zomato, Vodafone Idea among others will be in focus due to various news developments.

    LIC
    Sebi confirmed a securities market ban on five entities, including an employee of Life Insurance Corporation of India (LIC), in a case pertaining to front-running trades of the state-owned insurer.

    SBI Cards
    The Board of SBI Cards has declared an interim dividend of Rs 2.5 per share for the financial year ending 2023-24. The company has also fixed a record date of March 28 for the proposed dividend.

    Bharti Airtel
    Capital markets regulator Sebi approved the initial public offer (IPO) of Bharti Airtel's unit Bharti Hexacom.

    Read more: Here's the trade setup for today's session

    Zomato
    Zomato Founder and CEO Deepinder Goyal announced the launch of a "Pure Veg Mode" service to cater to customers who have pure vegetarian dietary preference.

    Vodafone Idea
    Vodafone Idea said American Tower Corp (ATC) Telecom Infrastructure has requested conversion of debentures worth Rs 1440 crore into equity shares.

    Protean eGov Technologies
    Sudeep Bhatia has resigned as the CFO of Protean eGov Technologies with effect from June 14, 2024 citing personal reasons.

    Aurobindo Pharma
    Aurobindo Pharma has received final approval from the USFDA to manufacture and market Mometasone Furoate Monohydrate Nasal Spray, 50 mcg/spray. The product will be launched in Q1FY25.


    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more

    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in